About us

About us

Atrial Fibrillation (AF) affects 100 million people worldwide. People with AF have a significant risk of stroke and death and need treatment urgently. However, recurrence after treatment is still not optimal and 20% will have recurrence within one year and 75% within 5 yrs. More accurate and reliable treatments are needed. Today, there are two dominant technologies for treating these patients: Radiofrequency Ablation (RFA) and Pulsed Field Ablation (PFA), both delivered by a cardiologist or electrophysiologist via catheter. Ablation catheters, today, are used blindly and without the ability to see target tissue as it is treated or assessed in real-time for quality and durability of these treatments.

Introducing MedLumics AblaView ®

MedLumics is a Madrid based start-up company developing the world’s first patented RFA and PFA catheter system with fiberoptic real-time vision. This system enables cardiologists to watch tissue as it’s being treated, improving accuracy, reliability and safety. We have completed an initial 10-patient clinical study with 3-month follow-up and the system works as designed with 100% predictive lesion durability.

AblaView® – Three key components come together for direct real-time visualization of AF ablation. All mechanical, electrical, hardware, firmware and software are being developed and manufactured by the experienced MedLumics management and manufacturing teams.

1. Ablation Catheter: Single-use disposable, dual-energy capable ablation catheter with integral fiber optics to project and receive laser light for analysis of tissue treatment in real time.

2. Optical Console:  designed and developed to be a unique laser light projector, receiver and OCR processor, delivering real-time visual data as tissue treatment is delivered. The Optical Console can switch between and control two types of ablation energy (RFA and PFA).

3. RF and PF Generator:  controlled by the optical console for delivering ablation energy as directed by the electrophysiologist.

Our Team

Our Team

Management Team

Management Team

Peter Hinchliffe

CEO

Hassan Osman

COO

Christophe Bailleul

VP Clinical & RA-QA

Lucía Colmenero

Director, Finance & HR

Board of Directors

Board of Directors

Mathieu Pieronne

Peter Neubeck

Diego Braguglia

Sylvain Sachot

Pablo Cironi

Peter Hinchliffe

Chairman

Investors

Investors

Get in touch

MedLumics is a medical device company founded in 2011 with the goal of taking the latest technological and scientific developments in biophotonics and turning them into innovative and quality products to improve quality of life.

Visit us

Plaza de la Encina 10-11 Núcleo 3 2ºA

28760 Tres Cantos – Madrid – Spain

Phone: +34 91 803 39 25

    Name

    Your Email

    Message

    I have read and expressly authorize the processing of personal data that may be collected, including those relating to their form of expression, verbal and physical, the assessments made on their character, all with the sole purpose of assessing your candidacy. Privacy Policy

    Security Check

    Please enter the text below

    captcha

    MedLumics
    Privacy Summary

    MedLumics uses cookies which are necessary for the proper functioning of its websites, to optimize the functionality of the site and ensure that we give the best user experience.